PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.39 -0.01 (-1.63%)
As of: Nov 12, 2026 · 10:14 AM EST

PharmaCyte Biotech (PMCB) Gross Margin (2009 - 2012)

Updated

PharmaCyte Biotech (PMCB) recorded Gross Margin of 20.89% in FY2013 (year ended Apr 30, 2013), down 49.99 percentage points from 70.88% in FY2012.

Analysis

PharmaCyte Biotech (PMCB) Gross Margin (2009 - 2012) Analysis & Trends

  • Per Business Quant data, PMCB's Gross Margin was 70.88% in FY2012 (-3.64 pp) and 74.52% in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 68.12%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 75.38%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 72.95%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.03%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 73.10%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 81.07%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 75.71%
10 PharmaCyte Biotech 4.29 Mn -68.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2012 -53.01%
Jul 31, 2012 100.00%
Apr 30, 2012 167.94%
Jan 31, 2012 89.09%
Oct 31, 2011 69.58%
Jul 31, 2011 20.68%
Apr 30, 2011 99.33%
Jan 31, 2011 31.36%
Oct 31, 2010 82.02%
Jul 31, 2010 74.31%
Apr 30, 2010 -80.20%
Jan 31, 2010 39.58%
Oct 31, 2009 25.94%
Jul 31, 2009 38.49%
Apr 30, 2009 -256.91%
Jan 31, 2009 76.01%
API Access

PharmaCyte Biotech Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=PMCB&period=max&api_key=YOUR_API_KEY